CNBC Halftime Report Final Trades: iShares U.S. Healthcare ETF, Truist Financial, Target

IYH Beats IXJ on Returns While Global Fund Offers Higher Yield

iShares U.S. Healthcare ETF (IYH) outperformed its global counterpart (IXJ) with 28.8% one-year returns versus 22.5%, while IXJ offers higher dividend yield at 1.4%. Both funds have nearly identical expense ratios (0.37-0.38%) and low volatility, with choice depending on whether investors prefer domestic or international healthcare exposure.

Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH

The Invesco Nasdaq Biotechnology ETF (IBBQ) offers lower costs (0.19% expense ratio) and higher 1-year returns (44.6%), making it suitable for growth-focused investors willing to accept volatility. The iShares U.S. Healthcare ETF (IYH) provides broader diversification across 100 healthcare holdings with higher dividend yield (1.1%) and lower volatility, appealing to conservative investors seeking stability and income.

Target, Truist Financial And More On CNBC’s ‘Final Trades’

CNBC’s final trades: Joshua Brown picks Target, Stephanie Link chooses Truist Financial, and Shannon Saccocia recommends iShares U.S. Healthcare ETF.

UBS Maintains Neutral on Truist Financial, Lowers Price Target to $50

JP Morgan Maintains Underweight on Truist Financial, Lowers Price Target to $50.5

JP Morgan analyst Vivek Juneja maintains Truist Financial (NYSE:TFC) with a Underweight and lowers the price target from $54 to $50.5.

Evercore ISI Group Maintains Outperform on Truist Financial, Lowers Price Target to $54